Earnings Feed
Start Free
Home/Filings/4/0001209191-05-052704
4//SEC Filing

HURWITZ EDWARD 4

Accession 0001209191-05-052704

CIK 0001138812other
View on SEC.govCompany Profile

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 1:16 PM ET

Size

26.2 KB

Accession

0001209191-05-052704

Insider Transaction Report

Form 4
Period: 2005-10-14
COTHERIX INCCTRX
DELEAGE JEAN
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
MARDUEL ALIX
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
PENHOET EDWARD
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    62,226

  • Common Stock

    (indirect: See footnotes)
    2,301,037
ALTA BIOPHARMA PARTNERS III LP
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
NOHRA GUY P
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
ALTA PARTNERS II INC
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
GRUENER GARRETT
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    62,226

  • Common Stock

    (indirect: See footnotes)
    2,301,037
CHAMPSI FARAH
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    62,226

  • Common Stock

    (indirect: See footnotes)
    2,301,037
HURWITZ EDWARD
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    2,301,037

  • Common Stock

    (indirect: See footnotes)
    62,226
Alta Partners III, Inc.
10% Owner
Transactions
  • Sale

    Common Stock

    2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    62,226

  • Common Stock

    (indirect: See footnotes)
    2,301,037
Footnotes (8)
  • [F1]Not applicable
  • [F2]Alta BioPharma Partners III, L.P. sold 152,900 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for a total of $1,987,700.00.
  • [F3]Daniel Janney, Director, is a managing director of Alta California Management Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII") & a manager of Alta Embarcadero Partners III, LLC ("AEPIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEPIII. He is a member of Alta BioPharma Management III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of their proportionate pecuniary interests therein.
  • [F4]Alta Partners II, Inc. & Alta Partners III, Inc. provide investment advisory services to several funds including ACPIII, AEPIII, ABPIII, Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG") & Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The managing directors ("md") of ABMPIII (which is the gp of ABPIII & ABPIIIKG) & managers of AEBPIII, exercise sole voting & investment powers with respect to the sh ("sh")owned by such funds. G Gruener, G Nohra & D Janney (collectively known as the "principals") are md of ACMPIII & managers of AEPIII. J Deleage, F Champsi, A Marduel, E Hurwitz & E Penhoet (collectively known as the "principals") are directors of ABMPIII (which is the gp of ABPIII & ABPIIIKG & managers of AEBPIII, The principals may be deemed to share voting & investment powers over the sh held by the funds. The principals disclaim beneficial ownership of all such sh held by the funds, except to the extent of their porportionate pecuniary interest therein.
  • [F5]Alta BioPharma Partners III GmbH & Co. Beteiligungs KG sold 10,268 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for a total of $133,484.00.
  • [F6]Alta Embarcadero BioParma Partners III, LLC sold 3,769 shares of Common Stock at the Issuer's Follow-on Public Offering for $13.00/sh for a total of $48,997.00.
  • [F7]Alta California Partners III, L.P. holds 2,301,037 shares of Common Stock.
  • [F8]Alta Embarcadero Partners III, LLC holds 62,226 shares of Common Stock.

Documents

1 file

Issuer

COTHERIX INC

CIK 0001138812

→
Entity typeother

Related Parties

1
  • filerCIK 0001211840

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 1:16 PM ET
Size
26.2 KB
View on SEC.gov